About HF0-1234ze(E)
HFO-1234ze(E) FAQs
Solstice® Air
Honeywell’s Solstice® Air (HFO-1234ze(E), cGMP) is an alternative medical propellant with a GWP 99.9% lower than propellants currently used in inhaled respiratory medicines. Solstice® Air is the only non-flammable, near-zero GWP propellant available and in clinical development today for pMDIs.
For references and more information, see:
Solstice Air Overview
News
-
OzUK announces new GLP pilot plant for development of MDIs with LGWP propellants
-
Honeywell announces agreement to supply HFO 1234ze for DevPro albuterol MDI, spin off of the advanced materials business
-
Bespak and H&T Presspart launch new GMP pilot-scale MDI filling line for LGWP propellants
-
AstraZeneca says that it has completed studies to support regulatory submissions for LGWP propellant version of Breztri (Trixeo) Aerosphere MDI
-
Bespak announces that it will soon allocate capacity for new LGWP MDI filling line
-
Bespak and DevPro developing HFO-1234ze albuterol MDI
-
DDL 2023 highlighted novel technologies
-
Oz-UK adds manufacturing line for MDIs with LGWP propellants
-
Recipharm announces appointment of Simon Gardner as Business Development Specialist, partnership with Oz-UK on LGWP MDIs
-
Kindeva and Koura partner on conversion of existing MDI to HFA 152a
Contact Us: Click Here
Page sponsored by Honeywell